Wuhan Fortuna Chemical Co., Ltd.
Main products:piracetam,DL-carnitine HCL,Gardenin,Ceftriaxone Sodium,Flunixin Meglumine
Products
Contact Us
  • Contact Person : Ms. Shu Betty
  • Company Name : Wuhan Fortuna Chemical Co., Ltd.
  • Tel : 86-27-51505023
  • Fax : 86-27-51505022
  • Address : Hubei,Wuhan,314# Xinhua Road, Jianghan District,Wuhan
  • Country/Region : China
  • Zip : 430022

Company Profile
Wuhan Fortuna Chemical Co., Ltd., located in Wuhan City, known as a traffic hinge of China, is a big integrative chemical enterprise, engaged in producing and developing pharmaceutical & its intermediates and food additives and distributing the products of our own company and affiliated enterprises.

Our company has professional staff members who deal with chemical R&D and scientific management, and holds several analyzing instruments with high efficiency and high sensitivity, such as HPLCs, GCs and Spectrophotometers. Meanwhile, we possess complete Q.A. and Q.C. systems, and supply good quality and custom-tailored products according to our clients' requirements.

Since Fortuna Chemical was founded, we have continuously made innovation and improved our service and sales network. Hence, we initiate the first sales mode on net in China, which is the retail trade of small package, bringing along wholesale of diversified management modes. Our products are distributed to Japan, the USA, Europe and Southeast Asia, highly recommended by our clients.

We insist on the management creed of "Market is our compass; Quality is our life; Credit is our soul; Client's trust is our forward power; Client's satisfaction is our struggling goal".

Company Tenet: Creating much more value for our clients
Company Spirit: Based upon honesty, Depending on Credit, Relying on Diligence
Company Info
Basic Information
Company Name:
Wuhan Fortuna Chemical Co., Ltd.
Business Type:
Manufacturer
Product/Service:
piracetam,DL-carnitine HCL,Gardenin,Ceftriaxone Sodium,Flunixin Meglumine
Year Established:
2006
Trade & Market


Copyright Notice @ 2008-2022 ECVERY Limited and/or its subsidiaries and licensors. All rights reserved.